HomeNews

News

News

Therapy Intensification Adoption Variations Throughout Prostate Most cancers

Editor -
Findings from the IMPLEMENT sub-analysis investigating sufferers with metastatic castration-sensitive prostate most cancers present variations in remedy intensification adoption between tutorial and nonacademic...
News

EBRT Regimens Present Lengthy-Time period Survival Outcomes in Prostate Most cancers

Editor -
Sufferers with intermediate-risk prostate most cancers had a 15-year prostate most cancers–particular survival price of 91% with EBRT, with or with out short-term...
News

Opdivo Plus Cometyx Secure, Efficient in Superior Renal Cell Carcinoma

Editor -
Opdivo plus Cometyx resulted in a profit versus Sutent within the first-line of superior renal cell carcinoma remedy. © inventory.adobe.comAmongst sufferers with beforehand...
News

Outcomes Could Be Constant With Fotivda Alone or With Opdivo in Kidney Most cancers Subset

Editor -
Affected person-reported outcomes had been comparable for Fotivda with or with out Opdivo in superior clear cell RCC: © inventory.adobe.comIncluding Fotivda (tivozanib) to...
News

Antitumor Exercise Elicited in ccRCC Following Lenvima/Welireg Therapy

Editor -
Amongst sufferers with clear cell renal cell carcinoma, improved responses have been noticed with Lenvima plus Welireg versus Keytruda plus Lenvima. © unlimit3d...
1...440441442...672Page 441 of 672

Hot Topics

Load more

Quick Links

Must Read

Popular Articles

© 2024 Cancer Care Portal. All rights reserved.